Danaher Corporation A.I CyberSecurity Scoring
04/04/2026
Access Monitoring Plan
Access Monitoring Plan
No incidents recorded for Danaher Corporation in 2026.
No incidents recorded for Danaher Corporation in 2026.
No incidents recorded for Danaher Corporation in 2026.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We advance our mission to alleviate pain and improve the quality of life for patients around the world with our innovative products and suite of integrated digital and robotic technologies leverage data, data analytics and artificial intelligence. Founded in 1927 and based in Warsaw, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. We maintain world-class scientific facilities and resources and collaborate with leading clinicians and researchers around the world. Awards and Recognitions • Forbes: America's Best Companies 2026 • Workhuman: Luminary Award 2025 & Innovator Award 2024 • TIME: America's Best Companies [Mid-Size] 2024 • Great Place to Work - Best Workplaces: Switzerland & Poland 2025 • Great Place to Work Certified 2025 - 2026: USA, Poland, India, Colombia, Ireland, Puerto Rico, Kingdom of Saudi Arabia, Switzerland • MedTech: Breakthrough Award Best New Technology Solution in Orthopedics 2025 • Top Employers Institute: China 2025 • VETS Indexes: 4 Star Employer 2025
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at stryker.com and careers.stryker.com. Facts: ● 2024 Sales: $22.6 billion ● Industry: Medical Instruments & Supplies ● Employees: 53,000 worldwide ● 44+ Manufacturing and R&D Locations Worldwide ● $1.5 billion spent on research and development in 2024 ● ~14,200 patents owned globally in 2024 ● Products sold in ~75 countries ● Fortune 500 Company ● 9 consecutive years as one a World's Best Workplace Stryker’s social media community guidelines: https://www.stryker.com/content/m/legal/social-media-community-guidelines/en/index.html Notice Regarding Employee Conduct on Facebook/LinkedIn Meta/LinkedIn does not permit employers to verify or validate “employees” in the (META: “Works at” LinkedIn: “Experience”) section of users’ profiles. Please be aware that the views expressed by individuals on their personal accounts and do not necessarily represent the views of our company. If you encounter any issues with a person claiming to be our employee, we recommend using the “Report Profile” feature. If you’d like to report concerns to our Ethics Hotline, you may do so at: https://app.convercent.com/en-us/LandingPage/b6bb4e84-9fcb-ea11-a974-000d3ab9f296
BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com. See community guidelines here: bit.ly/4vTpKjz
Olympus is passionate about creating customer-driven solutions for the medical industry. For more than 100 years, Olympus has focused on making people’s lives healthier, safer and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 31,000 employees worldwide in nearly 40 countries and regions.
Smith+Nephew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nephew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can-do attitude, we work together to win.. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited. Please note: not all products referred to may be approved for use or available in all markets.
Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its unique offering of world-class products, supply chain resilience and clinical practice expertise, Medline delivers improved clinical, financial and operational outcomes. Headquartered in Northfield, Illinois, the company employs 43,000 people worldwide and operates in over 100 countries and territories. To learn more about how Medline makes healthcare run better, visit www.medline.com.
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company's sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
Latest updates, reports, and threat intel affecting the global network.
Stock futures are pointing lower Tuesday morning as the tech sell-off that dragged markets last week looks to be extending into this week.
Lugo believes security is a team sport which requires all people in an organization to manage, regardless of roles and responsibilities.
Stuart McClure, co-founder of cybersecurity firm Cylance, helped Irvine take a leadership position in artificial intelligence.
Founded: 1973. Number of employees: 1,001 - 5,000 employees. What they do: OCC encourages confidence in financial markets through a range of clearing,...
“Disruptive innovation” can conjure up images of flying cars, lightsabers, or a brave new world. But these technologies may not be as far off as they seem.
It is the sixth largest conglomerate in terms of market capitalization and operates in various industries such as aviation, healthcare, renewable energy, power...
They include a new chief customer officer at Ideagen and a new non-exec at cybersecurity software company Intercede.
Massive D.C. conglomerate Danaher Corp. (NYSE: DHR) is taking steps to spin off its environmental and applied sciences unit as a separate...
Highlights from Zimperium's Customer Panel at the Gartner Security & Risk Summit As the global leader in mobile security, Zimperium is proud...
A security vulnerability has been detected in Rizwan17 inventory-management-system up to bfe78a330d01bb26b9daec5dc9ecd5c77900e03f. This affects an unknown part of the file includes/invoice_bill.php of the component Invoice Generation. Such manipulation of the argument order_date/invoice_no leads to missing authentication. It is possible to launch the attack remotely. The exploit has been disclosed publicly and may be used. This product takes the approach of rolling releases to provide continious delivery. Therefore, version details for affected and updated releases are not available. The project was informed of the problem early through an issue report but has not responded yet.
A weakness has been identified in Rizwan17 inventory-management-system up to bfe78a330d01bb26b9daec5dc9ecd5c77900e03f. Affected by this issue is some unknown functionality of the file includes/DBOperation.php of the component List Handler. This manipulation of the argument category_name/brand_name/product_name causes cross site scripting. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be used for attacks. This product is using a rolling release to provide continious delivery. Therefore, no version details for affected nor updated releases are available. The project was informed of the problem early through an issue report but has not responded yet.
Authentication Bypass via Hardcoded Master Verification Code vulnerability in Siam Ordering (siam-server) 1.0.0 allows remote unauthenticated attackers to log in as any user, merchant, or administrator.
The Bluetooth Classic (BR/EDR) L2CAP receive handler bt_l2cap_br_recv() in subsys/bluetooth/host/classic/l2cap_br.c dispatched inbound data PDUs based only on the destination channel ID, without checking that the target channel had reached the BT_L2CAP_CONNECTED state. A dynamic channel is assigned its RX CID and added to the connection's channel list while still in BT_L2CAP_CONNECTING (and later BT_L2CAP_CONFIG) — before configuration completes and, for PSMs that require security, before the peer is authenticated (l2cap_br_conn_req()). Because the channel is already findable by bt_l2cap_br_lookup_rx_cid() during this window, a remote peer within radio range can send a data PDU addressed to that CID and have it processed on a not-yet-established channel. The dispatch keys off channel fields (BR_CHAN(chan)->rx.mode, rx.mps) that are only initialized during configuration by l2cap_br_conf(); since channel objects are pooled and bt_l2cap_br_chan_del() does not reset rx.mode or the reassembly buffer _sdu, a reused channel can carry stale state into the CONNECTING window and route the frame into the retransmission/flow-control path (bt_l2cap_br_ret_fc_recv()) with stale parameters and a possibly stale _sdu pointer. The impact is delivery of attacker data to upper-layer protocol handlers on a half-open (and possibly unauthenticated) channel, plus operation on stale or partially initialized channel state on reused channel objects — leading to channel/link teardown (denial of service) and, in the stale-_sdu case, a dangling-pointer condition. The fix adds an explicit BR_CHAN(chan)->state < BT_L2CAP_CONNECTED guard that drops any data received before the channel is fully connected.
Pandora contains a path traversal vulnerability in its archive extraction worker. When processing a specially crafted archive or disk image, attacker-controlled file paths could be used without ensuring that the resulting destination remained within the intended extraction directory. An attacker able to submit a malicious file for analysis could use path traversal sequences or crafted paths to cause extracted content to be written outside the designated extraction directory, potentially overwriting files accessible to the Pandora worker process. Successful exploitation could result in unauthorized modification of application or system files, denial of service, and potentially further compromise depending on the permissions of the Pandora process and the files that can be overwritten. The vulnerability is addressed by resolving each extraction destination path before writing and verifying that it remains below the expected extraction directory. Extraction attempts resolving outside this directory are rejected and reported as path traversal attempts.
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.